Ayala Pharmaceuticals Inc. (ADXS)

Ayala Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4.88	4.88	25.21	41.61	25.18	16.73
Cash & Cash Equivalents	4.88	4.88	25.21	41.61	25.18	16.73
Cash Growth	102.74%	-80.63%	-39.42%	65.28%	50.54%	-62.11%
Receivables	0	0	0.23	0.68	0.47	0.47
Inventory	0	0	-0.23	-0.68	1.34	0.08
Other Current Assets	2.65	2.65	0.55	1.64	0.87	0.42
Total Current Assets	7.53	7.53	25.76	43.26	27.85	17.69
Property, Plant & Equipment	0.64	0.64	0.05	0.16	7.23	1.42
Goodwill	4.5	4.5	0	0	0	0
Intangible Assets	4.25	3.9	0.11	3.35	3.26	4.58
Other Long-Term Assets	0.01	0.01	0.01	0.01	0.18	-3.64
Total Long-Term Assets	9.05	9.05	0.17	3.52	10.68	2.36
Total Assets	16.58	16.58	25.93	46.78	38.53	20.05
Accounts Payable	6.08	6.08	0.02	2.26	1.08	2.92
Deferred Revenue	6.34	6.34	0	0.67	0.17	0
Current Debt	0.17	0.17	0.01	0.03	0.96	0
Other Current Liabilities	12.44	12.44	2.27	4.93	1.08	2.38
Total Current Liabilities	25.02	25.02	2.3	7.88	3.29	5.3
Long-Term Debt	8.15	8.15	1.33	0.01	5.06	0.3
Other Long-Term Liabilities	7.83	7.83	1.34	0	0	0
Total Long-Term Liabilities	15.98	15.98	2.67	0.01	5.06	0.3
Total Liabilities	41	41	2.3	7.89	8.35	5.6
Total Debt	8.32	8.32	0.01	0.04	6.02	0.3
Debt Growth	374.93%	69200.00%	-70.00%	-99.34%	1912.37%	-
Common Stock	0.01	0.01	0	0.15	0.08	0.09
Retained Earnings	-197.23	-197.23	-442.96	-428.6	-410.74	-40.74
Shareholders' Equity	-24.42	-24.42	23.63	38.89	30.18	14.45
Total Liabilities and Equity	16.58	16.58	25.93	46.78	38.53	20.05
Net Cash / Debt	-3.43	-3.43	25.2	41.57	19.16	16.43
Net Cash / Debt Growth	-	-	-39.39%	116.97%	16.65%	-62.79%
Net Cash Per Share	-0.57	-0.57	13.85	25.76	25.13	86.41
Working Capital	-17.49	-17.49	23.46	35.38	24.56	12.39
Book Value Per Share	-4.06	-4.06	12.99	24.10	39.58	76.03

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.